The Immunomodulatory Potential Role of Mesenchymal Stem Cells in Diseases of the Central Nervous System
Neurodegenerative Diseases · 2022 · 22 (2) · 68-82
DOI: 10.1159/000528036 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Neurodegenerative Diseases, online erschienen am 17.11.2022. Verfasst von Rodrigo de Andrade Rufino und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Morphology and Genetics, Universidade Federal de São Paulo - UNIFESP, São Paulo, Brazil. Hauptthemen laut MEDLINE: Mesenchymal Stem Cells, Neurodegenerative Diseases, Multiple Sclerosis, Parkinson Disease. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 144 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Several studies indicate the role of mesenchymal stem cells (MSCs) as an important tool in regenerative medicine associated with injuries that affect the central nervous system (CNS). The MSCs have the capacity to differentiate into cells of the embryonic tissue, such as the mesoderm. So, these cells can be found in a variety of tissues. Also, the MSCs can release immunomodulatory and neurotrophic factors performance as inflammation mediators operating in injured tissue regeneration. Furthermore, they can differentiate into neural-like cells in vitro. Thereby, because of the high immunomodulatory role of MSCs, this review sought to describe the main immunomodulatory mechanisms performed by MSCs in CNS recovery after tissue injury or neurodegenerative diseases.
Methods
PubMed and ScienceDirect were searched between January 2011 to March 2021, and 43 articles met the criteria of the review.
Results
This systematic review indicates that MSCs were used in vivo experimental multiple sclerosis, Parkinson’s disease, Alzheimer’s disease, amyotrophic lateral sclerosis, ischemic stroke, and traumatic brain injury. The treatment MSCs were usually from human origin, derived from bone marrow, and administered intravenously.
Conclusion
It was shown that MSCs, independent from origin or administration pathway, can reduce inflammation and help in the recovery and preservation of injured neural tissue. Thus, the use of MSCs represents a potential therapeutic option in the treatment of neurological disorders mediated by inflammatory processes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Morphology and Genetics, Universidade Federal de São Paulo - UNIFESP, São Paulo, Brazil.
- Laboratory of Genetics, Instituto Butantan, São Paulo, Brazil.
Zitieren
APA
Rufino, R. A., Pereira-Rufino, L. D. S., Vissoto, T. C. S., Kerkis, I., Neves, A. D. C., & da Silva, M. C. P. (2022). The Immunomodulatory Potential Role of Mesenchymal Stem Cells in Diseases of the Central Nervous System. Neurodegenerative Diseases, 22(2), 68-82. https://doi.org/10.1159/000528036
Vancouver
Rufino RA, Pereira-Rufino LDS, Vissoto TCS, Kerkis I, Neves ADC, da Silva MCP. The Immunomodulatory Potential Role of Mesenchymal Stem Cells in Diseases of the Central Nervous System. Neurodegenerative Diseases. 2022;22(2):68-82. doi:10.1159/000528036
BibTeX
@article{Rufino2022,
author = {Rufino, Rodrigo de Andrade and Pereira-Rufino, Laís da Silva and Vissoto, Thays Cristina Silva and Kerkis, Irina and Neves, Adriana da Costa and da Silva, Marcelo Cavenaghi Pereira},
title = {The Immunomodulatory Potential Role of Mesenchymal Stem Cells in Diseases of the Central Nervous System},
journal = {Neurodegenerative Diseases},
year = {2022},
volume = {22},
number = {2},
pages = {68--82},
doi = {10.1159/000528036}
}
EUVIMED